Note 8. Income Taxes

 

Income tax provision (benefit) for the years ended December 31, 2025 and 2024 is summarized below:

 

   2025   2024 
Current:          
Federal  $-   $- 
State   -    - 
Total   -    - 
Deferred:          
Federal   (749,000)   (626,000)
State   752,000    1,270,000 
Change in valuation allowance   (288,000)   (644,000)
Total   (285,000)   - 
Benefit of income taxes  $(285,000)  $- 

 

The provision for income taxes differs from the amount computed by applying the statutory federal income tax rate before provision for income taxes. The sources and tax effect of the differences are as follows:

 

                
   2025   2024 
Statutory federal income tax rate  $(632,000)   21%   21%
State tax   (105,000)   3    4 
Permanent differences   164,000    (5)   - 
Change in valuation allowance   288,000    (10)   (25)
Net benefit of income taxes  $(285,000)   9%   -%

 

Components of the net deferred income tax assets at December 31, 2025 and 2024 were as follows:

 

   2025   2024 
Deferred tax asset - Net operating loss carryover  $13,920,000   $13,923,000 
Valuation allowance   (13,635,000)   (13,923,000)
Net deferred tax asset   285,000    - 
Deferred tax liability - depreciation   (285,000)   - 
Net deferred tax asset  $-   $- 

 

The Company recognized an income tax benefit of $285,000 related to the release of valuation allowance as a result of the Acquisition (Note 11). ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of evidence, it is more likely than not that some portion or all of the deferred tax assets will not be recognized. After consideration of all the evidence, both positive and negative, management has determined that a 100% valuation allowance, amounting to $13,635,000 and $13,923,000 at December 31, 2025 and 2024, respectively, is necessary to reduce the net deferred tax assets to the amount that will more likely than not be realized. The decrease in valuation allowance of $288,000 and $644,000 in 2025 and 2024, respectively, resulted from a lower blended state tax rate, partially offset by current year tax losses, and in 2025, deferred tax liabilities recognized in the Acquisition and adjustments to finalize the 2024 tax loss upon filing the tax returns.

 

 

As of December 31, 2025, the Company has a net operating loss carry forward to offset future taxable income of approximately $58,603,000, $28,482,000 of which begins to expire in 2033. Net operating loss carryforwards of $30,122,000 may be carried forward indefinitely.

 

The Company may have experienced an ownership change that could limit its ability to utilize its operating loss carryforward to offset taxable income in future years. An analysis will be required to determine whether such change has occurred, the outcome of which could impact the Company’s operating results and cash flow if and when it achieves profitability in taxable jurisdictions.

 

CARES Act

 

On March 27, 2020, the U.S. government enacted the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) to provide certain relief as a result of the COVID-19 pandemic. The CARES Act provides tax relief, along with other stimulus measures, including a provision for an Employee Retention Credit (“ERC”), which allows for employers to claim a refundable tax credit against the employer share of Social Security tax equal to 70% of the qualified wages paid to employees from the start of the COVID-19 pandemic through September 30, 2021. The ERC was designed to encourage businesses to keep employees on the payroll during the COVID-19 pandemic. The Company received a refund of $92,000 in March 2024.

 

ERC claims were permitted in a variety of circumstances with varying degrees of subjectivity and clear authoritative guidance. Paid claims are subject to IRS inspection which may occur at any time prior to expiration of the statute of limitations, generally two years from the date the refund was paid. The Company’s ERC claim was based on objectively calculated declines in revenue using methods that are clearly defined in the CARES Act and various regulations and interpretations thereof.

 

Historical Timeline

Fiscal YearFiled
2025Apr 15, 2026Showing above
2024Mar 27, 2025
2023Mar 22, 2024
2022Mar 2, 2023
2021Mar 10, 2022
2020Apr 14, 2021

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.